The post Cardano Price Falls 60% in a Year as Interest Reaches 5-Year Low appeared on BitcoinEthereumNews.com. Cardano traded near $0.3885 at the time of writingThe post Cardano Price Falls 60% in a Year as Interest Reaches 5-Year Low appeared on BitcoinEthereumNews.com. Cardano traded near $0.3885 at the time of writing

Cardano Price Falls 60% in a Year as Interest Reaches 5-Year Low

Cardano traded near $0.3885 at the time of writing, reflecting a monthly decline of nearly 6% and capping a brutal year for the token. ADA lost over 60% of its value over the past 12 months, sliding from a yearly high of $1.3245 to lows near $0.3512. 

Price weakness coincided with fading investor attention, as Google Trends data shows search interest falling to its lowest level in five years. What drove such a sharp disconnect between Cardano and the broader crypto narrative?

Broader Crypto Weakness Set the Tone

Cardano’s decline tracked a wider pullback across the digital asset market during 2025. Bitcoin fell over 6% over the same period, while Ethereum dropped roughly 11%. Total crypto market cap contracted by more than 8%, tightening liquidity across altcoins. 

ADA maintained a strong correlation with sector-wide moves, which amplified downside pressure during risk-off periods. As market momentum slowed, capital rotated toward assets with stronger near-term catalysts.

Ecosystem Growth Concerns Weighed on Sentiment

Attention also shifted to Cardano’s on-chain fundamentals. Data from DefiLlama shows total value locked on the network falling below $250 million. That figure places Cardano behind newer ecosystems such as Monad and Katana, despite its longer presence in the market. 

Source: DeFiLlama

Observers also noted Cardano’s limited exposure to the real-world asset tokenization sector, which has grown to nearly $20 billion in value. As a result, narratives around ecosystem stagnation gained traction and reduced speculative interest.

Institutional Participation Remained Limited

Institutional activity offered little support during the downturn. Only Grayscale submitted an application for a spot ADA exchange-traded fund, while firms such as BlackRock, 21Shares, VanEck, and Canary avoided the asset. 

This lack of institutional engagement contrasted sharply with growing interest in Bitcoin and Ethereum products. Without fresh inflows from large asset managers, ADA struggled to regain visibility during periods of market recovery.

Liquidations Accelerated the Downtrend

Market structure weakened further after a major liquidation event on October 10, when nearly two million traders exited leveraged positions across crypto markets. Cardano felt the impact through declining derivatives activity. Futures open interest dropped from over $1.95 billion in September to about $646 million. Deleveraging reduced volatility but also limited upside participation, keeping price action subdued through the final months of the year.

Forecast Points to Potential Rebound

Despite ongoing weakness, CoinCodex projects a possible recovery into 2026. Coincodex forecasts ADA rising by about 52% to $0.5916 by April 12, 2026. Technical indicators currently show bearish sentiment, while the Fear and Greed Index sits at 27, signaling fear-driven conditions.

Source: CoinCodex

Over the last 30 days, Cardano posted 10 green days with moderate volatility near 5.5%. These metrics highlight fragile confidence rather than capitulation.

Technical Structure Shows Early Stabilization

From a chart perspective, ADA has started forming higher lows after defending a key horizontal support zone. Price now approaches descending resistance, creating a potential inflection point.

A confirmed breakout could open a path toward the $0.52–$0.55 range, while rejection may trigger another test of recent lows. As 2026 approaches, traders continue to watch whether structure or sentiment leads the next move.

Source: https://coinpaper.com/13697/cardano-crashes-60-as-search-interest-hits-5-year-low-can-ada-recover-in-2026

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.719
$1.719$1.719
-1.54%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23